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Cannabis  use  in  adolescence  may  be characterized  by  differences  in the  neural  basis  of affective
processing.  In this  study,  we  used  an  fMRI  affective  face  processing  task  to compare  a large  group  (n  =  70)
of 14-year  olds  with  a history  of  cannabis  use  to a  group  (n  =  70)  of  never-using  controls  matched  on
numerous  characteristics  including  IQ,  SES,  alcohol  and  cigarette  use.  The  task  contained  short  movies
displaying  angry  and  neutral  faces.  Results  indicated  that  cannabis  users  had greater  reactivity  in the
bilateral  amygdalae  to  angry  faces  than  neutral  faces,  an  effect  that  was  not observed  in  their  abstinent
peers.  In contrast,  activity  levels  in  the cannabis  users  in cortical  areas  including  the  right  temporal-dolescence
ace processing
MRI
mygdala
motion
aces
parietal  junction  and  bilateral  dorsolateral  prefrontal  cortex  did  not  discriminate  between  the  two  face
conditions,  but  did  differ  in controls.  Results  did  not  change  after  excluding  subjects  with  any  psychiatric
symptomology.  Given  the  high  density  of  cannabinoid  receptors  in the  amygdala,  our  ﬁndings  suggest
cannabis  use in  early  adolescence  is  associated  with  hypersensitivity  to signals  of threat.  Hypersensitivity
to  negative  affect  in  adolescence  may  place the  subject  at-risk  for mood  disorders  in adulthood.
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. Introduction
Adolescence is a signiﬁcant period of psychosocial develop-
ent, with increases in novelty-seeking and risk-taking behaviors
Adriani et al., 1998; Romer et al., 2010; Trimpop et al., 1998).
xperimentation with drugs of abuse – especially alcohol, tobacco,
nd cannabis, is typically initiated during this phase (Chen and
andel, 1995). As cannabis becomes more available and pub-
ic opinion trends towards acceptance, adolescents may  have
ncreased access to the substance.
Current rates of cannabis use among adolescents are high, with
 quarter of all 10th graders, and over a third of all 12th graders
n the US reporting trying cannabis at least once (SAMHSA, 2014).
hronic use also appears to be growing; in 2008, 5.5% of users aged
2 and up reported near daily use while in 2013 this rate had risen
o 8.1% (SAMHSA, 2014). These increasing rates of use are conse-
uential in that about 10% of those who try cannabis will become
eekly users in adulthood (Hall and Pacula, 2003). Furthermore,
dolescent beliefs about the risks associated with cannabis appear
o be declining (Johnston et al., 2011).
Adolescence is also a period of marked neural development
ncluding gross volume changes, myelination, synaptic pruning,
nd receptor proliferation (Spear, 2000). These changes are espe-
ially large in the prefrontal cortex (PFC) (Gogtay et al., 2004;
hitford et al., 2007), amygdala, hippocampus, and striatum,
nd are governed in part by the endogenous cannabinoid system
Bossong and Niesink, 2010). Interestingly, the primary cannabi-
oid receptor, CB1, is found in high concentrations in these cogni-
ive and affective regions of the brain (Glass et al., 1997; Herkenham
t al., 1991; Katona et al., 2001), and appears to be fully expressed
y adolescence (Belue et al., 1995; de Fonseca et al., 1993; Morozov
nd Freund, 2003; Romero et al., 1997). Studies have shown that
xogenous cannabinoids can interfere with the endogenous system
Hoffman et al., 2007; Mato et al., 2004). Given the natural matura-
ion occurring in the brain during adolescence, and the propensity
owards cannabis use, the consumption of exogenous cannabinoids
uring adolescence may  disrupt typical neurodevelopment within
he cognitive and affective neural systems.
Mounting evidence supports the relationship between early
annabis use and mood disorders (Wittchen et al., 2007), even
ith relatively low levels of use (Cheung et al., 2010). Hence,
t is crucial to investigate the consequences of cannabis use on
motional development. Although numerous studies have associ-
ted cannabis use in adolescence with an increased likelihood of
chizophrenia and/or other affective disorders (Arseneault et al.,
004; Degenhardt and Hall, 2006; Fergusson et al., 2006; Hall, 2006;
inszen and van Amelsvoort, 2007; Manrique-Garcia et al., 2012)
here is relatively little research on the impact of cannabis use from
 cognitive and affective neuroscience perspective.
The amygdala has a high density of CB1 receptors, notably in the
asal and lateral nuclei (Katona et al., 2001). In adulthood, increased
mygdala activity is associated with major depressive disorder
Drevets, 2001; Sheline et al., 2001), and generalized social phobia
Evans et al., 2008; Phan et al., 2006). In adolescence, the amygdala
as found to yield stronger responses to fearful faces than adults
Thomas et al., 2001), and greater amygdala reactivity may  account
or adolescent vulnerability to mood disorders (Guyer et al., 2008a;
onk et al., 2008; Roberson-Nay et al., 2006). In consideration of
he amygdala’s role in the endocannabinoid system and affective
rocessing, adolescent vulnerability to mood disorders and propen-
ity for cannabis use, it is important to assess functional differences
n this region in cannabis-using teenagers.Using an animal model, Rubino and colleagues (2008), and
chramm-Sapyta and colleagues (2007) examined the relation-
hip between anxiety and THC exposure in adolescent and adult
ats. Findings indicate that adolescent rats exhibit elevated signs oftive Neuroscience 16 (2015) 63–70
anxiety, depression, and anhedonia when treated with THC com-
pared to placebo. Translating these ﬁndings to humans may  imply
cannabis use in adolescence is related to differences in the genera-
tion and regulation of affect.
To examine the impact of cannabis use on brain regions subserv-
ing emotional processing, we conducted an fMRI study on 14-year
old cannabis users vs. controls using affective face stimuli. Angry
and neutral faces provide a robust probe of activity within the
amygdala and PFC in adults (Morris et al., 1996; Pessoa et al., 2002;
Whalen et al., 1998), as well as children and adolescents (Baird et al.,
1999; Thomas et al., 2001). The differential activity of the amygdala
to angry versus neutral faces is an excellent index of emotional
processing and may  relate to psychopathology. However, in order
to prevent ceiling effects, we  used a set of stimuli that was only
mildly negatively valenced on the basis that they may  provide a
sensitive test of enhanced amygdala reactivity (Grosbras and Paus,
2006).
To date, few study have examined the relationship between
cannabis and face processing. Phan and colleagues (2008) recruited
healthy adults in a dual-session, double-blind, placebo-controlled
study of THC intoxication and face processing using fMRI. Find-
ings indicate THC attenuates the amygdala response to fearful
faces. Similarly, Gruber and colleagues (2009) studied 15 chronic
cannabis users vs. matched controls under fMRI during a masked
affective face processing task. Results suggest chronic cannabis use
is associated with decreased reactivity in the anterior cingulate
and amygdala. While both Phan and Gruber’s ﬁndings suggest anx-
iolytic effects in intoxicated adults, these studies do not address
whether the effects would replicate in users not intoxicated during
scanning, nor does it address whether the effects would generalize
to adolescents. Nonetheless, these studies provide evidence that
cannabis use is associated with differences in affective processing.
In this relatively large fMRI study (N = 140), we investigated
the impact of previous cannabis use (n = 70) compared to closely
matched controls (n = 70) in early adolescence using a face
processing task during fMRI. To date, there has been no previ-
ous research directly studying history of cannabis use with face
processing, especially not from a developmental affective neuro-
science perspective.
2. Methods
2.1. Participants
We  identiﬁed a sample of cannabis-experimenting adolescents
(n = 70) and matched controls (n = 70) from the IMAGEN dataset,
a large multi-site longitudinal study of adolescent development
(Schumann et al., 2010). The European School Survey Project on
Alcohol and Other Drugs (ESPAD) item for lifetime history of
cannabis use was used to identify the cannabis-experimenting
group. Subjects provided a self-report based on a scale from 0 to
6, (1 = 1–2 times; 3 = 6–9 times; 6 = 40+ times; see supplementary
Table S1 for complete distribution, and S2 for substance use age
of onset distributions). Subjects who endorsed using other illicit
substances were excluded, and any subject exhibiting signs of
intoxication were excluded from scanning.
Given the relationship between amygdalar reactivity and
psychopathology, subjects completed the Development and Well-
Being Assessment (DAWBA; Goodman et al., 2000) to screen for
psychopathology symptomology. DAWBA clinical rating scores
were obtained from trained DAWBA clinicians who generated clin-
ical rating scores by reviewing parent, teacher, and adolescent
DAWBA responses. Final scores consisted of one of three categories:
no-diagnosis, unsure, and, sure diagnosis, on any DSM-IV symptom
class of psychopathology. From our sample, ﬁve of the controls and
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Table  1
Subject information and statistics by group.
Measure Group p
Cannabis (n = 70) Controls (n = 70)
Males/females (n) 50/20 41/29 .111
Left/right handedness (n) 6/64 5/65 .753
Age  (M,  SD) 14.765, 0.40 14.61, 0.655 .607
Perceptual reasoning IQ
(M, SD)
104.219, 16.876 105.72, 13.879 .555
Verbal comprehension IQ
(M, SD)
110.74, 16.84 110.43, 13.329 .905
Puberty development
scale (M,  SD)
3.60, 0.60 3.766, 0.63 .585
Socioeconomic status (M,
SD)
18.45, 4.42 18.24, 4.70 .751
Any DSM-IV diagnoses
(n)
10 14 .275
Conduct disorder
diagnosis (n)
5 0 .019
Lifetime alcohol Use (M,
SD)
3.71, 1.63 3.56, 1.32 .530
Lifetime cigarette use (M,
SD)
3.106, 2.215 2.54, 2.215 .158
Lifetime cannabis Use (M,
SD)a
1.70, 1.30 0, 0 .000
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ﬂa Based on a self-report scale from 0 to 6. (1 = 1–2 times; 2 = 3–5 times; 3 = 6–9
imes; 4 = 10–19 times; 5 = 20–39 times; 6 = 40+ times).
ine of the cannabis-experimenting group did not complete the
AWBA. Nonetheless, subjects were matched to the best of our
bility on the DAWBA as indicated via chi-square analyses.
Controls were identiﬁed and matched on sex, handedness, age,
erbal comprehension and perceptual reasoning IQ, pubertal devel-
pment, socioeconomic status, and site. As cannabis use is highly
orrelated with alcohol and cigarette use (Hall and Pacula, 2003),
hich often makes it difﬁcult to attribute group differences to the
annabis use per se,  controls were also matched on lifetime alcohol
nd cigarette use. Chi-square tests were performed on the DAWBA,
ex, and handedness; t-tests were performed on the remaining
ontinuous measures (see Table 1 for subject information and p-
alues).
.2. Task
Participants passively viewed a collection of video clips that con-
ained either a person’s face or a control picture (concentric circles).
he task was designed and originally implemented by Grosbras and
aus (2006) and required participants to passively view a series
f short (2–5 s) black-and-white video clips showing a face that
tarted from a neutral expression and progressively turned angry,
r, progressively turned to a second neutral expression. The control
ictures contained expanding and contracting concentric circles of
arious contrasts, roughly matching the contrast and motion char-
cteristics of the faces. These control images were designed and
riginally implemented by Beauchamp and colleagues (2003) and
ere included to account for neural activity associated with view-
ng non-biological motion. All stimuli were presented as 18 s blocks,
ith 4–7 video clips per block during a face block. Each run was
omprised of 5 blocks of neutral faces and 5 blocks of angry faces.
.3. Imaging parameters
All MRI  data were acquired using 3T MRI  scanners made by sev-
ral manufacturers (Siemens, Philips, General Electric, Bruker) in
he eight IMAGEN assessment sites (London, Nottingham, Dublin,
annheim, Dresden, Berlin, Hamburg, and Paris). Important
canning parameters were identical across sites (i.e., ﬁeld of view,
ip angle and matrix; see Schumann et al., 2010) and followedtive Neuroscience 16 (2015) 63–70 65
an extensive program of cross-site standardization. Although our
groups were matched on site, each participant’s site was modeled
as a nuisance covariate in the statistical analyses. In the present
task, 160 volumes per subject were obtained, each comprising 40
slices. The slices were aligned to the connecting line between the
anterior and posterior commissure (2.4 mm thickness, 1 mm gap,
TR = 2.20 s, TE = 30 ms).
2.4. Imaging analysis
The pre-processing of the EPI data was  done within SPM8 (Sta-
tistical Parametric Mapping, http://www.ﬁl.ion.ucl.ac.uk/spm/).
Time series data were ﬁrst corrected for slice-timing, then corrected
for movement (spatial realignment), non-linearly warped into MNI
space (using a custom EPI template), and Gaussian-smoothed at
5 mm-FWHM.  Activation maps were computed with SPM8, and
regressed using a general linear model (GLM) with AR noise model
(SPM default) against a design-matrix modeling each event of the
stimulus presentation. Contrast images were obtained for the main
effect of angry faces and neutral faces, as well as the differential
activation for angry vs. neutral faces.
2.5. Preliminary analysis
A preliminary voxel-wise analysis directly comparing the
cannabis-experimenting group to the control group was conducted
using the AFNI toolbox (Cox, 1996). We  subjected the data to
a between-group t-test on the contrast image of angry minus
neutral face processing. We  detected greater differential activa-
tion to angry faces in the cannabis-experimenting group in small
clusters spanning potentially interesting cortical and subcortical
areas (dorsolateral prefrontal cortex, temporal parietal junction,
fusiform, and right extended amygdala into the striatum). However,
at a whole-brain uncorrected p < .005, the clusters were small and
consequently prompted a functionally deﬁned region-of-interest
analysis.
2.6. Voxel-wise analysis
The central goal of the voxel-wise analysis was  to ﬁnd unbi-
ased clusters of brain activation that discriminated between angry
and neutral faces. All cannabis-experimenting and control subjects
were combined and treated as one group in a t-test vs. zero using
the angry vs. neutral contrast. Scanning site was  used as a nuisance
covariate to account for the variance associated with multisite data
collection.
2.7. ROI selection
ROIs were deﬁned based on the results from the above voxel-
wise analysis. The alpha-level for cluster detection was  determined
by running Monte Carlo simulations using AFNI’s 3dClustSim. The
smoothness of the data was estimated using 3dFWHMx (details at
http://afni.nimh.nih.gov/pub/dist/doc/program help/). Based on a
voxel-wise uncorrected alpha of p = .005, a minimum cluster extent
was determined to be 112 contiguous voxels, so as to arrive at a cor-
rected ROI-level alpha of p = .01. From these criteria, we identiﬁed
seven regions that were signiﬁcantly more active for angry faces
relative to neutral faces.
Based on prior knowledge of the importance of the amygdala in
affective face processing, left and right anatomically deﬁned amyg-
dala ROIs were also included in the analysis. Amygdala ROIs were
obtained using the Eickhoff–Zilles macro label atlas in MNI  space
distributed within AFNI (Eickhoff et al., 2005). The voxels in the
amygdala ROIs were then resampled to match the grid dimensions
of the functional data.
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Table 2
Anatomically and functionally deﬁned ROIs with group by condition interaction statistics. Rows in bold survived a modiﬁed Bonferroni correction for multiple comparisons.
Peak voxel location Center of mass
coordinate (MNI)
Cluster size Group × condition
interaction
x, y, z k F p
Left amygdala 120 8.54 .000
Right  amygdala 139 5.56 .004
Right  middle temporal gyrus, cluster extends into temporal parietal junction (TPJ) −54, 47, 6 1333 5.28 .006
Left  inferior frontal gyrus, cluster extends into dorsolateral prefrontal cortex (dlPFC) 54, −14, 28 417 4.87 .008
Right  inferior frontal gyrus, cluster extends into dorsolateral prefrontal cortex(dlPFC) −49, −14, 33 356 5.71 .004
Left  middle temporal gyrus, cluster extends into temporal-parietal junction (TPJ) 53, 51, 9 1181 2.19 .115
Left  cerebellum 12, 78, -39 477 2.36 .096
Right  lingual gyrus −13, 79, -8 317 1.53 .219
Bilateral anterior cingulate, cluster extends into ventromedial prefrontal cortex 0, −45, 7 830 3.72 .026
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p = .006) (see Figs. 1–3 and Table 2).
Post hoc tests revealed that within the cannabis-experimenting
group, there were signiﬁcant differences in the bilateral amyg-
dalae with greater activation for the angry faces (right amygdalaig. 1. Mean activation for face type by group plotted for left and right amygdala
epresent the standard error of the mean.
.8. ROI analysis
The seven functionally deﬁned clusters, plus the left and right
mygdala ROIs, were used to extract the mean BOLD signal from the
ngry face and neutral face contrasts for all subjects. The mean sig-
al for each ROI were then subjected to a 2-by-2 (group × face type)
nalyses of variance using SPSS v. 22 (IBM Corp. Armonk, NY). All
-values reported were corrected for multiple comparisons using
 modiﬁed Bonferroni procedure (Keppel and Wickens, 2004). For
isplay purposes, the mean signal for face type by group was plot-
ed using MATLAB v. R2014a (The MathWorks, Inc., Natick, MA).
astly, we tested for any correlation between the mean signal per
ace type within all the ROIs with the level of cannabis use, and age
f onset of cannabis, alcohol, and cigarette use.
. Results
.1. Subjects
As shown in Table 1, the two groups did not differ in sex,
andedness, age, verbal or perceptual IQ, pubertal development,
ocioeconomic status, total (any) DSM-IV diagnoses, lifetime alco-
ol or cigarette use. Further, the cannabis-experimenting group’s
ean verbal and perceptual IQ did not signiﬁcantly differ from the
eans of the entire IMAGEN sample (N = 1849) at p < .05..2. Voxel-wise analysis results
Seven clusters were identiﬁed centered on the right and left
iddle temporal gyrus, right and left inferior frontal gyrus, bilat-
ral anterior cingulate, left cerebellum, and right lingual gyrus (see
able 2).isks indicate post hoc t-test differences signiﬁcant at p < .05, corrected. Error bars
3.3. ROI ANOVA results
As expected given how they were identiﬁed, all seven func-
tionally deﬁned ROIs, plus the amygdalae, exhibited a signiﬁcant
main effect of face type (F(9,130) = 30.03, p < .001). None showed
a main effect of group but, instead, ﬁve of the nine had sig-
niﬁcant interactions between face type and group. These ﬁve
were the left amygdala (F(1,138) = 8.54, p < .001); right amygdala
(F(1,138) = 8.54, p = .004); right middle temporal gyrus with extent
into temporal parietal junction (F(1,138) = 5.28, p = .006); left infe-
rior frontal gyrus with extent into dorsolateral prefrontal cortex
(F(1,138) = 4.87, p = .008); and right inferior frontal frontal gyrus
with extent into dorsolateral prefrontal cortex (F(1,138) = 5.71,Fig. 2. Mean activation for face type by group plotted for the cluster spanning the
right temporal parietal junction. Blue bars represent angry faces, red bars represent
neutral faces. Asterisks indicate post hoc t-test differences signiﬁcant at p < .05, cor-
rected. Error bars represent the standard error of the mean (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web  version of
this article.).
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Fig. 3. Mean activation for face type by group plotted for the cluster spanning the left and right dorsolateral prefrontal cortex. Blue bars represent angry faces, red bars
r  < .05,
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aepresent neutral faces. Asterisks indicate post hoc t-test differences signiﬁcant at p
For  interpretation of the references to color in this ﬁgure legend, the reader is refe
(69) = 4.02, p < .001; left amygdala t(69) = 3.15, p = .002) but no
ffect of face type on activity in the cortical ROIs.
Controls showed a different pattern; there were signiﬁcant face
ype differences in all the cortical regions with greater activation
or neutral faces, but no effect of face type on the BOLD signal in the
mygdalae (right middle temporal gyrus t(69) = −7.20, p < .001; left
nferior frontal gyrus t(69) = −5.13, p < .001; right inferior frontal
yrus t(69) = −5.68, p < .001: see Table 3 for all post hoc t-test
esults).
. ROI Correlations with Other Drugs
To examine dosage–response effects, we investigated Pearson’s
orrelation on frequency of cannabis use with the mean signal per
ace type within each region. Dosage effects within bilateral amyg-
alae and dlPFC were non-signiﬁcant at p < .05. Interestingly, we
etected a signiﬁcant correlation within the right TPJ cluster with
requency of cannabis use. Both the mean signal related to angry
aces (r = −.25, p < .05), and neutral faces (r = −.26, p < .05), was cor-
elated with frequency of cannabis use, such that, more frequent
annabis use is associated with less processing by the right TPJ
uring presentation of both face types.
We  also investigated Pearson’s correlation on age of onset of
annabis, alcohol, and cigarette use with the mean signal per face
ype within each ROI. However, we failed to detect any signiﬁcant
orrelations at p < .05 between age of onset for any drugs of abuse
ith any of the ROIs.
able 3
ost hoc t-test comparison for within-group differences. Cells in bold are signiﬁcant
t  p < .05, corrected.
Angry faces vs. neutral faces
Cannabis Controls
Left amygdala t(69) = 4.02, p < .001 t(69) = −0.32, p = .750
Right amygdala t(69) = 3.15, p = .002 t(69) = −0.73, p = .470
Right middle temporal
gyrus, cluster extends
into temporal parietal
junction (TPJ)
t(69) = −1.21, p = .231 t(69) = −7.20, p < .001
Left inferior frontal gyrus,
cluster extends into
dorsolateral prefrontal
cortex (dlPFC)
t(69) = −0.60, p = .551 t(69) = −5.13, p < .001
Right inferior frontal gyrus,
cluster extends into
dorsolateral prefrontal
cortex (dlPFC)
t(69) = −0.56, p = .576 t(69) = −5.68, p < .001 corrected. Error bars represent the standard error of the mean. Cutout: y = 4, z = 48
 the web  version of this article.).
4.1. Psychopathology Symptomology
The DAWBA clinical rating scores revealed 14 cannabis-
experimenters and 10 control subjects (X2(1,122) = 1.19, p > .05)
were identiﬁed as having a “sure” DSM-IV symptom class diag-
noses. Chi-square analyses revealed the only symptom class that
signiﬁcantly differed between the two groups was conduct disor-
der: X2(1,122) = 5.55, p < .05. This ﬁnding is consistent with previous
studies reporting an association between conduct disorder and
cannabis use initiation during adolescence (Castellanos-Ryan and
Conrod, 2011; Hopfer et al., 2013).
4.2. Inﬂuence of Psychopathology
To examine if the conduct disorder ﬁnding was related to our
results, we  ﬁrst excluded the ﬁve subjects with a conduct disor-
der diagnosis and re-ran the ANOVA and post hoc t-tests. Both the
ANOVA and post hoc t-tests results remained the same as the initial
analysis with all subjects included. We  then tested to see if conduct
disorder in the cannabis-experimenting group was  correlated with
the BOLD signal in any of the ROIs, but failed to detect any signiﬁcant
correlation at p < .05.
Lastly, to test if any psychopathology inﬂuenced the dataset, we
excluded all 14 cannabis-experimenting and 10 control subjects
with a strong probability of a DSM-IV category diagnosis from the
ANOVA and post hoc t-tests, and reran the analyses. When correct-
ing for multiple comparisons, the left and right amygdala and right
TPJ maintained signiﬁcance on the ANOVA face type × group inter-
action. Nonetheless, the same ﬁve regions that initially survived
correction for multiple comparisons for the full sample analysis
still passed signiﬁcance at an uncorrected p-value of <.05. Addition-
ally, the post hoc t-test results remained the same. Consequently,
with minor exceptions regarding correction for multiple compar-
isons, results remained largely the same even when analyzed on
sub-groupings devoid of any mental health symptomology. Hence,
these ﬁndings suggest that mental health symptomology was  not
contributing to the full sample group differences.
5. Discussion
In this study, we  examined the functional neurobiology of angry
and neutral face processing in a group of cannabis-experimenting
adolescents vs. matched controls using fMRI. We  found group-
by-face type interaction effects in bilateral amygdala and three
clusters of activation that span the right TPJ and bilateral dlPFC.
Decomposing these results by face type, we found the cannabis-
experimenting group exhibited increased activity to angry faces in
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he amygdala. Conversely, the control group exhibited increased
ctivity to neutral faces in the cortical regions. Therefore, cannabis
se during early adolescence is associated with hypersensitivity to
egative affect in the amygdala. While we stress that this study
oes not permit us to conclude cannabis-experimentation caused
he observed functional neurobiological differences, we  are conﬁ-
ent these differences are associated with the cannabis use status
f the participants due to our relatively large sample size (N = 140),
arefully matched control group (who did not differ on sex, puber-
al development, IQ, site, psychopathology, or alcohol and cigarette
se), and a conservative criteria to meet statistical signiﬁcance.
With regard to the cortical ﬁndings, the right TPJ and bilat-
ral dlPFC showed greater activation to neutral faces than angry
aces in the control group. The right TPJ has been implicated in the-
ry of mind, social processing, and face processing (Allison et al.,
000; Saxe and Kanwisher, 2003; Saxe and Powell, 2006). Fur-
hermore, the right superior temporal gyrus encodes biologically
elevant motion (Grossman et al., 2000; Puce and Perrett, 2003;
aygin, 2007). Therefore this cluster may  represent a signal of social
alience related to the moving face stimuli. In contrast to controls,
ost hoc t-test results show the cannabis-experimenting group fails
o process angry faces differently from neutral faces within the right
PJ (see Fig. 2). As this region was also the only region to exhibit
igniﬁcant dosage effects, a higher degree of cannabis experimenta-
ion may  contribute to a departure from healthy social processing.
nterestingly, as none of the regions exhibited a signiﬁcant corre-
ation with age of onset for any drugs of abuse, we  are unable to
ake claims regarding face processing and cannabis use in relation
o age of onset with other drugs.
Considering that the cortical clusters spanned the temporal,
arietal, and bilateral frontal lobes, we suggest that the neutral
aces demanded more cognitive resources. The neutral faces had
reater ambiguity and variability in their content, such as nose
witching, mouth movements, and eye-blinks. Furthermore, all
timuli video clips started from neutral and transitioned to angry
r neutral faces. The stimuli that transitioned to angry faces were
ore explicit during the shift to threat, whereas the transition to
nother neutral face may  have required more cognitive strategies
o decode. Hence, the neutral faces may  have demanded a greater
egree of attention and interpretation by these cognitive systems.
With regard to the amygdala ﬁndings, it is unclear whether
mygdala hypersensitivity preceded cannabis use or was  a conse-
uence of use since this was a cross-sectional study. If amygdala
ypersensitivity preceded use, which might seem most plausible
iven the low levels of reported use, then it’s possible that these
ndividuals may  have been inclined to self-medicate for the drug’s
cute anxiolytic effects (Phan et al., 2008). Consistent with this
nterpretation, recent evidence has identiﬁed altered angry face
rocessing in the ventromedial PFC (vmPFC) to predict future
inge drinking (Whelan et al., 2014) and the vmPFC is part of
 brain circuit that attenuates amygdala activity (Banks et al.,
007; Urry et al., 2006). If, however, the amygdala hypersensitivity
s a consequence of cannabis use, then it is likely that this is
ue to exogenous stimulation of the endocannabinoid system. If
onﬁrmed, these ﬁndings would raise concerns regarding the risks
ssociated with cannabis consumption and emotional health in
dolescent users. Animal studies suggest exogenous cannabinoids
nhibit GABAergic neurotransmission in the amygdala (Katona
t al., 2001). Interestingly, this effect is magniﬁed when the animal
s given THC and placed in a threatening environment (Patel et al.,
004). Together these ﬁndings suggest that cannabinoids may
ompromise the major neuronal inhibitory mechanism within the
mygdala and lower the threshold for activation, especially during
ignals of threat. Consistent with this interpretation, the angry
aces used in the task were not exceptionally potent signals of
hreat yet the cannabis-experimenting group showed a heightenedtive Neuroscience 16 (2015) 63–70
reactivity to them, an effect that is not observed in healthy controls
viewing the same stimuli (Grosbras and Paus, 2006).
The amygdala’s role in affective processing serves an impor-
tant role in evolutionary biology as it directs attention towards
aversive stimuli. However, mounting evidence suggests that over-
recruitment of the amygdala is associated with various mood
disorders. Greater signal change in the amygdala, speciﬁcally dur-
ing affective face processing, is exhibited by children with anxiety
(Thomas et al., 2001), and adults with major depressive disorder
(Drevets, 2001; Fu et al., 2008; Sheline et al., 2001) and generalized
social phobia (Evans et al., 2008; Phan et al., 2006). Thus, cannabis
use in adolescence may  contribute to the etiology of mood disor-
ders in adulthood. Moreover, relatively light use by an early age may
contribute to an early marker of maladaptive affective processing.
Nonetheless, major longitudinal studies are needed to illuminate
these hypotheses as the current study is unable to infer causality.
The results reported here are inconsistent with those of Phan
and colleagues (2008) and Gruber and colleagues (2009) who both
found attenuated amygdala reactivity to threat signals in adults
following acute THC administration, and chronic non-intoxicated
users, respectively. In contrast, we  report trait-related increased
amygdala reactivity to threat signals in adolescence. Hence, we
report divergent effects in adolescents compared to adults. As
previous research demonstrates divergent ﬁndings between ado-
lescents and adults during affective face processing (Guyer et al.,
2008a,b), we  do not hypothesize adolescent data to mirror the adult
data. Indeed, our results support the notion that adolescence is
period of sensitive affective development that can be perturbed
even with very low levels of cannabis experimentation.
The current results are consistent with the animal models of
cannabinoid exposure during adolescence (Rubino et al., 2008;
Schramm-Sapyta et al., 2007) and suggest that more human
research is needed on the long-term effects of cannabis use in
adolescence. In consideration of the animal studies and the link
between early cannabis use and mood disorders later in life, acute
THC consumption effects in the adolescent brain may  be different
or, indeed, the long-lasting effects of repeated exposure may  be dif-
ferent beyond the acute intoxication phase. As adolescents tend to
be more reactive to emotional stimuli, especially face processing
in the amygdala, the observed differences in adolescent cannabis-
users may  suggest evidence of maladaptive cognitive and affective
systems related to psychosocial development.
Lastly, a notable feature of the present results is that our sam-
ple of cannabis users reported relatively low levels of use, but
nonetheless exhibited signiﬁcant differences in processing threat
signals. Furthermore, due to the closely matched control group, we
excluded a range of possible confounding factors, including mental
health comorbidities, which may  have accounted for the observed
differences. As excluding subjects with mental health comorbidi-
ties failed to change the pattern of our results, the ﬁndings suggests
that very low use of cannabis during early adolescence may  com-
promise healthy emotional reactivity.
An alternative explanation regarding the observed differences
in affective face processing may  be attributed to unmeasured pre-
existing differences in emotional functioning, which might have
contributed to the adolescents’ experimentation with cannabis.
Indeed, we have previously shown that activation in response to
these angry faces in the left PFC predicted binge drinking two
years later, which would suggest altered emotional reactivity may
precede use (Whelan et al., 2014). However, in the present analyses
the measured psychiatric symptomology results failed to show ele-
vated levels of any of the affective disorders, therefore, it is unclear
which preexisting differences, if any, might have been present in
the cannabis-experimenting group.
Future studies will be performed on the follow-up (age 16 and
18) data of this project to identify predictive factors contributing
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o the cannabis use phenotype proﬁle. As this was  a cross-sectional
tudy from the baseline IMAGEN dataset, we  stress that we  are
nable to claim cannabis use caused amygdala hypersensitivity to
egative affect. To investigate this question, longitudinal data anal-
sis will inform whether hypersensitivity to threat signals precedes
se or is a consequence of use, and assessments of psychopathology
ill clarify if early cannabis use and differences in face processing
ontribute to the generation of clinically relevant disorders.
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